IPO Lockup Expiration Alert: ALX Oncology Holdings Inc. (ALXO)

The lockup period of Burlingame, California-based ALX Oncology Holdings Inc. (ALXO) ends on January 13. ALX Oncology Holdings is a clinical-stage immuno-oncology company developing therapies targeting CD47 checkpoint pathway for blood and solid tumor cancers.